NCT00565760View on ClinicalTrials.gov

Extension Study to Evaluate the Safety of Q8003 in Patients With Acute Moderate to Severe Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Acute Moderate to Severe Pain
Interventions
DRUG

Q8003

Capsules

DRUG

Placebo

Capsules

Trial Locations (6)

16602

Advanced Regional Center for Foot and Ankle Care, Altoona

21122

Chesapeake Research Group, Pasadena

77081

Scirex Research Center, Houston

84106

Lifetree Clinical Research, Salt Lake City

84124

Jean Brown Research, Salt Lake City

92801

Advanced Clinical Research Institute, Anaheim

All Listed Sponsors
lead

QRxPharma Inc.

INDUSTRY

NCT00565760 - Extension Study to Evaluate the Safety of Q8003 in Patients With Acute Moderate to Severe Pain | Biotech Hunter | Biotech Hunter